{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:07Z","timestamp":1759047007712,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.imlet.2022.06.007","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T11:00:17Z","timestamp":1655550017000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4361-821X","authenticated-orcid":false,"given":"Espiridi\u00f3n","family":"Ramos-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6877-8124","authenticated-orcid":false,"given":"Ramc\u00e9s","family":"Falf\u00e1n-Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6876-1012","authenticated-orcid":false,"given":"Gloria","family":"P\u00e9rez-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra","family":"Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Guillermo","family":"Mej\u00eda-Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2825-506X","authenticated-orcid":false,"given":"Ivette","family":"Buend\u00eda-Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0405-5466","authenticated-orcid":false,"given":"Montserrat I.","family":"Gonz\u00e1lez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidegger N.","family":"Mateos-Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6980-7898","authenticated-orcid":false,"given":"Jorge","family":"Rojas-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.imlet.2022.06.007_bib0001","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi","year":"2017","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.imlet.2022.06.007_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051356","article-title":"Anti-aminoacyl transfer-RNA-synthetases (Anti-tRNA) autoantibodies associated with interstitial lung disease: pulmonary disease progression has a persistent elevation of the Th17 cytokine profile","volume":"9","author":"Ramos-Martinez","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4\u20135","key":"10.1016\/j.imlet.2022.06.007_bib0003","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","volume":"13","author":"Mahler","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J. Bras. Pneumol."},{"issue":"4","key":"10.1016\/j.imlet.2022.06.007_bib0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European respiratory society\/American thoracic society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.imlet.2022.06.007_bib0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","article-title":"Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)","volume":"80","author":"Spagnolo","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.imlet.2022.06.007_bib0007","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/RHU.0b013e3181b0e910","article-title":"Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience","volume":"15","author":"Mileti","year":"2009","journal-title":"J. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/thx.2006.069237","article-title":"Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset","volume":"63","author":"Tillie-Leblond","year":"2008","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.imlet.2022.06.007_bib0009","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern. Med."},{"issue":"145","key":"10.1016\/j.imlet.2022.06.007_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0009-2017","article-title":"The role of macrophages in interstitial lung diseases: number 3 in the series \u201cpathology for the clinician\u201d edited by peter dorfmuller and alberto cavazza","volume":"26","author":"Rossi","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"9","key":"10.1016\/j.imlet.2022.06.007_bib0011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/08958378.2016.1188186","article-title":"Dynamic changes of mononuclear phagocytes in circulating, pulmonary alveolar and interstitial compartments in a mouse model of experimental silicosis","volume":"28","author":"Xiang","year":"2016","journal-title":"Inhal. Toxicol."},{"issue":"12","key":"10.1016\/j.imlet.2022.06.007_bib0012","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2022.06.007_bib0013","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.imlet.2022.06.007_bib0014","doi-asserted-by":"crossref","first-page":"F52","DOI":"10.1152\/ajprenal.00260.2018","article-title":"Macrophage-secreted TGF-beta1 contributes to fibroblast activation and ureteral stricture after ablation injury","volume":"317","author":"Ueshima","year":"2019","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"2","key":"10.1016\/j.imlet.2022.06.007_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/ar1504","article-title":"Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases","volume":"7","author":"Wahl","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0016","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biocel.2010.10.013","article-title":"TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P","volume":"43","author":"Murray","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.2370","article-title":"Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas","volume":"216","author":"Komohara","year":"2008","journal-title":"J. Pathol."},{"issue":"2\u20134","key":"10.1016\/j.imlet.2022.06.007_bib0018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.imbio.2005.05.010","article-title":"The macrophage scavenger receptor CD163","volume":"210","author":"Fabriek","year":"2005","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0019","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000109414.78907.F9","article-title":"Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery","volume":"94","author":"Philippidis","year":"2004","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1189\/jlb.1205756","article-title":"Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163","volume":"80","author":"Weaver","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.imlet.2022.06.007_bib0021","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.27129","article-title":"Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C","volume":"60","author":"Kazankov","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.imlet.2022.06.007_bib0022","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5152\/eurjrheum.2016.15088","article-title":"Serum soluble CD163 and its association with various disease parameters in patients with systemic sclerosis","volume":"3","author":"Hassan","year":"2016","journal-title":"Eur. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.imlet.2022.06.007_bib0023","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1172\/JCI135439","article-title":"Long noncoding RNA H19X is a key mediator of TGF-beta-driven fibrosis","volume":"130","author":"Pachera","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.imlet.2022.06.007_bib0024","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor beta-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2022.06.007_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2249.2010.04094.x","article-title":"Inhibition of transforming growth factor-beta signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice","volume":"160","author":"Segawa","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2022.06.007_bib0026","article-title":"Evolution of pulmonary function in a cohort of patients with interstitial lung disease and positive for antisynthetase antibodies","author":"Gonzalez-Perez","year":"2019","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2022.06.007_bib0027","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","article-title":"Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay","volume":"49","author":"Ghirardello","year":"2010","journal-title":"Rheumatology"},{"issue":"19","key":"10.1016\/j.imlet.2022.06.007_bib0028","doi-asserted-by":"crossref","first-page":"e25816","DOI":"10.1097\/MD.0000000000025816","article-title":"Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies","volume":"100","author":"Jiang","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.imlet.2022.06.007_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/JAA.S104508","article-title":"Update on the role of alternatively activated macrophages in asthma","volume":"9","author":"Jiang","year":"2016","journal-title":"J. Asthma Allergy"},{"issue":"2","key":"10.1016\/j.imlet.2022.06.007_bib0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.imbio.2016.10.003","article-title":"Pneumocystis infection alters the activation state of pulmonary macrophages","volume":"222","author":"Deckman","year":"2017","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.imlet.2022.06.007_bib0031","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/toxsci\/kfy039","article-title":"Cypermethrin promotes lung cancer metastasis via modulation of macrophage polarization by targeting MicroRNA-155\/Bcl6","volume":"163","author":"Huang","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0032","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","article-title":"A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement","volume":"19","author":"Trombetta","year":"2018","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0033","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-016-1214-8","article-title":"Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease","volume":"19","author":"Enomoto","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.007_bib0034","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5114\/ada.2017.71358","article-title":"The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report","volume":"35","author":"Owczarczyk-Saczonek","year":"2018","journal-title":"Postepy Dermatol. Alergol."},{"issue":"3","key":"10.1016\/j.imlet.2022.06.007_bib0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Joint Bone Spine"},{"issue":"23","key":"10.1016\/j.imlet.2022.06.007_bib0036","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0024-3205(00)00559-2","article-title":"Effects of methotrexate on nucleotide pools in normal human T cells and the CEM T cell line","volume":"66","author":"Budzik","year":"2000","journal-title":"Life Sci."},{"issue":"Pt 1","key":"10.1016\/j.imlet.2022.06.007_bib0037","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj3420143","article-title":"Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?","volume":"342","author":"Fairbanks","year":"1999","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.imlet.2022.06.007_bib0038","first-page":"3395","article-title":"TGF-beta1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2\/3 signalling pathway","volume":"42","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.imlet.2022.06.007_bib0039","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"Lee","year":"2011","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.imlet.2022.06.007_bib0040","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","article-title":"Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases","volume":"99","author":"Piera-Velazquez","year":"2019","journal-title":"Physiol. Rev."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:41:35Z","timestamp":1759045295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247822000943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"alternative-id":["S0165247822000943"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2022.06.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2022.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}